Initial infant colonization results from genetics, microbial exposures such as delivery mode and antibiotic usage, and breast feeding. This, in turn, sets in motion the cross-talk between the microbiome, nutrition, immunity, barrier function, metabolism and gene expression. The initial colonization of the infant and microbiome-directed therapies represent a major avenue for prevention and treatment of immune and metabolic disease.